Updated time: 2024-06-27 11:56:23
28A-1071101
2020-10-19
CN 114144188B、USP patent pending
Cell-free DNA (cfDNA), cell-free RNA (cfRNA) and vesicular RNA (vcRNA) carry important genetic information of medical implications and are thus becoming valuable noninvasive specimens for diagnosis of many diseases including cancer. However, application of next-generation sequencing (NGS) in sequencing of cfDNA, cfRNA and vcRNA is frequently hampered by low quantity and/or poor quality. To overcome these problems, we invented this novel method for reverse transcription and amplification of minute RNA fragments for sequencing and conventional diagnosis. This method has a number of biological and medical implications.
- Method for amplifying and detecting on cfRNA and vcRNA, including non-coding RNA.
- Only need a few RNAs for amplifying and detecting.
- Our protocol produces a single-type (homogeneous) adaptor.
- Amplifying RNA-derived cDNA by TOP-PCR is using single primer (either T oligo or U-containing T oligo).
- Biological research.
- Diagnosis and early detection of cancer.
- Diagnosis and early detection of other genetic diseases.
Kuo-Ping Chiu、Hsin-Chieh Shiau、Zee Hong Goh
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Method for amplifying and detecting ribonucleic acid (RNA) fragments